No Cover Image

Journal article 703 views

Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke

Subodh Verma, Neil R. Poulter, Deepak L. Bhatt, Steve Bain Orcid Logo, John B. Buse, Lawrence A. Leiter, Michael A. Nauck, Richard E. Pratley, Bernard Zinman, David D. Ørsted, Tea Monk Fries, Søren Rasmussen, Steven P. Marso, (For the LEADER Publication Committee on Behalf of the LEADER Trial Investigators)

Circulation, Volume: 138, Issue: 25, Pages: 2884 - 2894

Swansea University Author: Steve Bain Orcid Logo

Full text not available from this repository: check for access using links below.

Published in: Circulation
ISSN: 0009-7322 1524-4539
Published: Ovid Technologies (Wolters Kluwer Health) 2018
Online Access: Check full text

URI: https://cronfa.swan.ac.uk/Record/cronfa48035
Tags: Add Tag
No Tags, Be the first to tag this record!
first_indexed 2019-01-04T20:00:23Z
last_indexed 2020-07-25T03:08:17Z
id cronfa48035
recordtype SURis
fullrecord <?xml version="1.0"?><rfc1807><datestamp>2020-07-24T19:38:22.7989851</datestamp><bib-version>v2</bib-version><id>48035</id><entry>2019-01-04</entry><title>Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke</title><swanseaauthors><author><sid>5399f4c6e6a70f3608a084ddb938511a</sid><ORCID>0000-0001-8519-4964</ORCID><firstname>Steve</firstname><surname>Bain</surname><name>Steve Bain</name><active>true</active><ethesisStudent>false</ethesisStudent></author></swanseaauthors><date>2019-01-04</date><deptcode>BMS</deptcode><abstract/><type>Journal Article</type><journal>Circulation</journal><volume>138</volume><journalNumber>25</journalNumber><paginationStart>2884</paginationStart><paginationEnd>2894</paginationEnd><publisher>Ovid Technologies (Wolters Kluwer Health)</publisher><issnPrint>0009-7322</issnPrint><issnElectronic>1524-4539</issnElectronic><keywords/><publishedDay>18</publishedDay><publishedMonth>12</publishedMonth><publishedYear>2018</publishedYear><publishedDate>2018-12-18</publishedDate><doi>10.1161/circulationaha.118.034516</doi><url/><notes/><college>COLLEGE NANME</college><department>Biomedical Sciences</department><CollegeCode>COLLEGE CODE</CollegeCode><DepartmentCode>BMS</DepartmentCode><institution>Swansea University</institution><apcterm/><lastEdited>2020-07-24T19:38:22.7989851</lastEdited><Created>2019-01-04T15:26:14.6550607</Created><path><level id="1">Faculty of Medicine, Health and Life Sciences</level><level id="2">Swansea University Medical School - Medicine</level></path><authors><author><firstname>Subodh</firstname><surname>Verma</surname><order>1</order></author><author><firstname>Neil R.</firstname><surname>Poulter</surname><order>2</order></author><author><firstname>Deepak L.</firstname><surname>Bhatt</surname><order>3</order></author><author><firstname>Steve</firstname><surname>Bain</surname><orcid>0000-0001-8519-4964</orcid><order>4</order></author><author><firstname>John B.</firstname><surname>Buse</surname><order>5</order></author><author><firstname>Lawrence A.</firstname><surname>Leiter</surname><order>6</order></author><author><firstname>Michael A.</firstname><surname>Nauck</surname><order>7</order></author><author><firstname>Richard E.</firstname><surname>Pratley</surname><order>8</order></author><author><firstname>Bernard</firstname><surname>Zinman</surname><order>9</order></author><author><firstname>David D.</firstname><surname>&#xD8;rsted</surname><order>10</order></author><author><firstname>Tea Monk</firstname><surname>Fries</surname><order>11</order></author><author><firstname>S&#xF8;ren</firstname><surname>Rasmussen</surname><order>12</order></author><author><firstname>Steven P.</firstname><surname>Marso</surname><order>13</order></author><author><firstname>(For the LEADER Publication Committee on Behalf of the LEADER Trial</firstname><surname>Investigators)</surname><order>14</order></author></authors><documents/><OutputDurs/></rfc1807>
spelling 2020-07-24T19:38:22.7989851 v2 48035 2019-01-04 Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke 5399f4c6e6a70f3608a084ddb938511a 0000-0001-8519-4964 Steve Bain Steve Bain true false 2019-01-04 BMS Journal Article Circulation 138 25 2884 2894 Ovid Technologies (Wolters Kluwer Health) 0009-7322 1524-4539 18 12 2018 2018-12-18 10.1161/circulationaha.118.034516 COLLEGE NANME Biomedical Sciences COLLEGE CODE BMS Swansea University 2020-07-24T19:38:22.7989851 2019-01-04T15:26:14.6550607 Faculty of Medicine, Health and Life Sciences Swansea University Medical School - Medicine Subodh Verma 1 Neil R. Poulter 2 Deepak L. Bhatt 3 Steve Bain 0000-0001-8519-4964 4 John B. Buse 5 Lawrence A. Leiter 6 Michael A. Nauck 7 Richard E. Pratley 8 Bernard Zinman 9 David D. Ørsted 10 Tea Monk Fries 11 Søren Rasmussen 12 Steven P. Marso 13 (For the LEADER Publication Committee on Behalf of the LEADER Trial Investigators) 14
title Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke
spellingShingle Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke
Steve Bain
title_short Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke
title_full Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke
title_fullStr Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke
title_full_unstemmed Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke
title_sort Effects of Liraglutide on Cardiovascular Outcomes in Patients With Type 2 Diabetes Mellitus With or Without History of Myocardial Infarction or Stroke
author_id_str_mv 5399f4c6e6a70f3608a084ddb938511a
author_id_fullname_str_mv 5399f4c6e6a70f3608a084ddb938511a_***_Steve Bain
author Steve Bain
author2 Subodh Verma
Neil R. Poulter
Deepak L. Bhatt
Steve Bain
John B. Buse
Lawrence A. Leiter
Michael A. Nauck
Richard E. Pratley
Bernard Zinman
David D. Ørsted
Tea Monk Fries
Søren Rasmussen
Steven P. Marso
(For the LEADER Publication Committee on Behalf of the LEADER Trial Investigators)
format Journal article
container_title Circulation
container_volume 138
container_issue 25
container_start_page 2884
publishDate 2018
institution Swansea University
issn 0009-7322
1524-4539
doi_str_mv 10.1161/circulationaha.118.034516
publisher Ovid Technologies (Wolters Kluwer Health)
college_str Faculty of Medicine, Health and Life Sciences
hierarchytype
hierarchy_top_id facultyofmedicinehealthandlifesciences
hierarchy_top_title Faculty of Medicine, Health and Life Sciences
hierarchy_parent_id facultyofmedicinehealthandlifesciences
hierarchy_parent_title Faculty of Medicine, Health and Life Sciences
department_str Swansea University Medical School - Medicine{{{_:::_}}}Faculty of Medicine, Health and Life Sciences{{{_:::_}}}Swansea University Medical School - Medicine
document_store_str 0
active_str 0
published_date 2018-12-18T03:58:19Z
_version_ 1763752961328021504
score 11.012678